199 related articles for article (PubMed ID: 29770709)
1. Lessons learned from the PRESERVE trial.
Partovi S; Trischman T; Kang PS
Br J Radiol; 2018 Jul; 91(1087):20180092. PubMed ID: 29770709
[TBL] [Abstract][Full Text] [Related]
2. Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.
Weisbord SD; Gallagher M; Kaufman J; Cass A; Parikh CR; Chertow GM; Shunk KA; McCullough PA; Fine MJ; Mor MK; Lew RA; Huang GD; Conner TA; Brophy MT; Lee J; Soliva S; Palevsky PM
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1618-31. PubMed ID: 23660180
[TBL] [Abstract][Full Text] [Related]
3. Acute kidney injury: Antioxidants do not PRESERVE kidney function after contrast exposure.
Solomon R
Nat Rev Nephrol; 2018 Mar; 14(3):148-149. PubMed ID: 29355174
[No Abstract] [Full Text] [Related]
4. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.
Weisbord SD; Gallagher M; Jneid H; Garcia S; Cass A; Thwin SS; Conner TA; Chertow GM; Bhatt DL; Shunk K; Parikh CR; McFalls EO; Brophy M; Ferguson R; Wu H; Androsenko M; Myles J; Kaufman J; Palevsky PM;
N Engl J Med; 2018 Feb; 378(7):603-614. PubMed ID: 29130810
[TBL] [Abstract][Full Text] [Related]
5. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.
Brown JR; Block CA; Malenka DJ; O'Connor GT; Schoolwerth AC; Thompson CA
JACC Cardiovasc Interv; 2009 Nov; 2(11):1116-24. PubMed ID: 19926054
[TBL] [Abstract][Full Text] [Related]
6. In search of an algorithm to prevent acute kidney injury.
Dauerman HL
JACC Cardiovasc Interv; 2009 Nov; 2(11):1125-7. PubMed ID: 19926055
[No Abstract] [Full Text] [Related]
7. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.
Ma WQ; Zhao Y; Wang Y; Han XQ; Zhu Y; Liu NF
Int Urol Nephrol; 2018 Jun; 50(6):1085-1095. PubMed ID: 29404930
[TBL] [Abstract][Full Text] [Related]
8. Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention: A Subgroup Analysis of the PRESERVE Trial.
Garcia S; Bhatt DL; Gallagher M; Jneid H; Kaufman J; Palevsky PM; Wu H; Weisbord SD;
JACC Cardiovasc Interv; 2018 Nov; 11(22):2254-2261. PubMed ID: 30466822
[TBL] [Abstract][Full Text] [Related]
9. Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial.
Parikh CR; Liu C; Mor MK; Palevsky PM; Kaufman JS; Thiessen Philbrook H; Weisbord SD
Am J Kidney Dis; 2020 Feb; 75(2):187-194. PubMed ID: 31547939
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta-analysis.
Zhang B; Liang L; Chen W; Liang C; Zhang S
BMJ Open; 2015 Mar; 5(3):e006989. PubMed ID: 25783425
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.
Reinecke H; Fobker M; Wellmann J; Becke B; Fleiter J; Heitmeyer C; Breithardt G; Hense HW; Schaefer RM
Clin Res Cardiol; 2007 Mar; 96(3):130-9. PubMed ID: 17180572
[TBL] [Abstract][Full Text] [Related]
12. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
13. How to protect from contrast media-induced nephropathy?
Scheller B
Clin Res Cardiol; 2007 Mar; 96(3):125-9. PubMed ID: 17294353
[No Abstract] [Full Text] [Related]
14. Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial.
Inda-Filho AJ; Caixeta A; Manggini M; Schor N
PLoS One; 2014; 9(9):e107602. PubMed ID: 25254489
[TBL] [Abstract][Full Text] [Related]
15. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
16. Contrast-induced acute kidney injury: the at-risk patient and protective measures.
Brown JR; Thompson CA
Curr Cardiol Rep; 2010 Sep; 12(5):440-5. PubMed ID: 20640537
[TBL] [Abstract][Full Text] [Related]
17. Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.
Shavit L; Korenfeld R; Lifschitz M; Butnaru A; Slotki I
J Interv Cardiol; 2009 Dec; 22(6):556-63. PubMed ID: 19732281
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Intravenous and Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Low-Risk Patients: A Randomized Trial.
Martin-Moreno PL; Varo N; Martínez-Ansó E; Martin-Calvo N; Sayón-Orea C; Bilbao JI; Garcia-Fernandez N
Nephron; 2015; 131(1):51-8. PubMed ID: 26336919
[TBL] [Abstract][Full Text] [Related]
19. Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Heng AE; Cellarier E; Aublet-Cuvelier B; Decalf V; Motreff P; Marcaggi X; Deteix P; Souweine B
Clin Nephrol; 2008 Dec; 70(6):475-84. PubMed ID: 19049703
[TBL] [Abstract][Full Text] [Related]
20. Acetylcysteine and contrast agent-associated nephrotoxicity.
Briguori C; Manganelli F; Scarpato P; Elia PP; Golia B; Riviezzo G; Lepore S; Librera M; Villari B; Colombo A; Ricciardelli B
J Am Coll Cardiol; 2002 Jul; 40(2):298-303. PubMed ID: 12106935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
